Aiming for patient safety indicators in radiation oncology – Results from a systematic literature review as part of the PaSaGeRO study

• Published in: Radiotherapy and oncology 2025-02, Vol.203, p.110657, Article 110657
• Main Authors: Baehr, Andrea, Grohmann, Maximilian, Christalle, Eva, Schwenzer, Felicitas, Scholl, Isabelle
• Format: Article
• Language: English
• Subjects: Patient safety indicators; Radiation oncology; Risk management; Safety assessment; Safety culture; Systematic review
• ISSN: 0167-8140; 1879-0887; 1879-0887
• DOI: 10.1016/j.radonc.2024.110657

•This systematic review identified 145 patient safety indicators specific to radiation oncology.•Indicators include four main categories with focus on patient-specific processes.•This research provides a foundation for developing tools to assess and enhance patient safety. Patient Safety Indicators (PSIs) allow the evaluation of safety levels in healthcare settings. Despite their use in various medical fields, a specific and comprehensive PSI catalogue for radiation oncology (RO) is lacking. The Patient Safety in German Radiation Oncology (PaSaGeRO) study aims for the development of a specific PSI catalogue in radiation oncology. The primary objective of this systematic literature review as part of the PaSaGeRO study is to identify, formulate, and categorize PSIs specific to RO to bridge existing gaps in comprehensive patient safety evaluation. An electronic search in PubMed included studies from 1989 onwards, in English or German, focusing on safety and quality indicators in RO, patient safety measures, or risk analyses. Exclusions were non-transferable, country-specific measures, techniques exclusive to specific departments, and legally mandated procedures. Additional sources were identified through reference tracking and professional society websites. Two experts independently extracted PSIs from the included references. Out of 157 included publications and nine secondary sources, we identified and formulated 145 PSIs. These were categorized into patient-specific processes (82, 56%), quality and risk management (42, 28%), human resources (15, 10%), and institutional culture (13, 9%). The hereby developed PSIs provides a base for professionals to systematically evaluate and improve safety practices, addressing previously unmet needs in this field. By offering clear guidance on safety assessment, the catalogue has the potential to drive significant improvements in patient care and safety outcomes in RO. Funded by Deutsche Krebshilfe. Registered in the German Clinical Trials Register (DRKS00034690).